首页> 美国卫生研究院文献>Oxidative Medicine and Cellular Longevity >Therapeutic Efficacy of Topically Applied Antioxidant Medicinal Plant Extracts in a Mouse Model of Experimental Dry Eye
【2h】

Therapeutic Efficacy of Topically Applied Antioxidant Medicinal Plant Extracts in a Mouse Model of Experimental Dry Eye

机译:局部应用抗氧化剂药用植物提取物在实验性干眼小鼠模型中的治疗功效

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Purpose. To investigate the therapeutic effects of topical administration of antioxidant medicinal plant extracts in a mouse model of experimental dry eye (EDE). Methods. Eye drops containing balanced salt solution (BSS) or 0.001%, 0.01%, and 0.1% extracts were applied for the treatment of EDE. Tear volume, tear film break-up time (BUT), and corneal fluorescein staining scores were measured 10 days after desiccating stress. In addition, we evaluated the levels of interleukin- (IL-) 1β, tumor necrosis factor- (TNF-) α, IL-6, interferon- (IFN-) γ, and IFN-γ associated chemokines, percentage of CD4+C-X-C chemokine receptor type 3 positive (CXCR3+) T cells, goblet cell density, number of 4-hydroxy-2-nonenal (4-HNE) positive cells, and extracellular reactive oxygen species (ROS) production. Results. Compared to the EDE and BSS control groups, the mice treated with topical application of the 0.1% extract showed significant improvements in all clinical parameters, IL-1β, IL-6, TNF-α, and IFN-γ levels, percentage of CD4+CXCR3+ T cells, goblet cell density, number of 4-HNE-positive cells, and extracellular ROS production (P < 0.05). Conclusions. Topical application of 0.1% medicinal plant extracts improved clinical signs, decreased inflammation, and ameliorated oxidative stress marker and ROS production on the ocular surface of the EDE model mice.
机译:目的。调查局部给药抗氧化剂药用植物提取物在实验性干眼症(EDE)小鼠模型中的治疗效果。方法。含有均衡盐溶液(BSS)或0.001%,0.01%和0.1%提取物的滴眼液用于治疗EDE。干燥应力后10天,测量眼泪体积,眼泪膜破裂时间(BUT)和角膜荧光素染色评分。此外,我们评估了白介素-(IL-)1β,肿瘤坏死因子-(TNF-)α,IL-6,干扰素-(IFN-)γ和IFN-γ相关趋化因子的水平,CD4 + CXC的百分比趋化因子受体3型阳性(CXCR3 +)T细胞,杯状细胞密度,4-羟基-2-壬烯醛(4-HNE)阳性细胞数量以及细胞外活性氧(ROS)产生。结果。与EDE和BSS对照组相比,局部应用0.1%提取物治疗的小鼠在所有临床参数,IL-1β,IL-6,TNF-α和IFN-γ水平,CD4 +百分比方面均表现出显着改善CXCR3 + T细胞,杯状细胞密度,4-HNE阳性细胞数和细胞外ROS产生(P <0.05)。结论。局部应用0.1%的药用植物提取物可改善EDE模型小鼠眼表的临床体征,减轻炎症,减轻氧化应激标记物和ROS的产生。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号